ExodusPoint Capital Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-22,386
Closed -$15.1M 1803
2025
Q4
$15.1M Buy
+22,386
New +$15.2M 0.12% 152
2025
Q1
Sell
-55,793
Closed -$23.1M 1714
2024
Q4
$23.1M Buy
+55,793
New +$24.5M 0.16% 107
2024
Q1
Sell
-5,497
Closed -$3.05M 1699
2023
Q4
$3.05M Buy
5,497
+2,885
+110% +$1.35M 0.02% 457
2023
Q3
$1.14M Buy
+2,612
New +$1.3M 0.01% 913
2023
Q2
Sell
-11,286
Closed -$5.64M 2035
2023
Q1
$5.64M Sell
11,286
-5,122
-31% -$2.45M 0.05% 473
2022
Q4
$6.69M Buy
16,408
+6,842
+72% +$2.66M 0.1% 273
2022
Q3
$3.12M Buy
+9,566
New +$3.51M 0.04% 577
2022
Q2
Sell
-11,485
Closed -$6.28M 2152
2022
Q1
$6.28M Buy
+11,485
New +$6.04M 0.08% 319
2021
Q4
Sell
-25,650
Closed -$16M 2365
2021
Q3
$16M Buy
25,650
+23,929
+1,390% +$16.1M 0.22% 100
2021
Q2
$1.09M Sell
1,721
-8,839
-84% -$4.88M 0.01% 967
2021
Q1
$5.17M Buy
10,560
+8,556
+427% +$4.29M 0.08% 256
2020
Q4
$1M Buy
+2,004
New +$897K 0.01% 858
2020
Q1
Sell
-3,627
Closed -$947K 1337
2019
Q4
$947K Buy
+3,627
New +$956K 0.02% 574
2019
Q3
Sell
-2,312
Closed -$637K 1472
2019
Q2
$637K Buy
+2,312
New +$570K 0.03% 380
2019
Q1
Sell
-1,893
Closed -$352K 711
2018
Q4
$352K Buy
+1,893
New +$388K 0.02% 179

Other funds holding IDXX

ExodusPoint Capital Management's IDXX Position: Q1 2026 in Review

ExodusPoint Capital Management sold out of Idexx Laboratories (IDXX) in Q1 2026, closing a stake of 22,386 shares — an estimated $15.1M sold.

ExodusPoint Capital Management first reported a position in IDXX in Q4 2018 and held it in 15 quarters. The position peaked at $23.1M in Q4 2024. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • ExodusPoint Capital Management reported no remaining Idexx Laboratories position as of Q1 2026 after selling out during the quarter.
  • ExodusPoint Capital Management sold 22,386 Idexx Laboratories shares in Q1 2026, an estimated $15.1M.
  • ExodusPoint Capital Management first reported a position in Idexx Laboratories in Q4 2018 and held it in 15 quarters.
  • ExodusPoint Capital Management's Idexx Laboratories position peaked at $23.1M in Q4 2024.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.